Prostate cancer specific survival. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Prostate Cell Line, Tumor Tumor Cells, Cultured Epithelial Cells Neoplastic Stem Cells Chromosomes, Human, Pair 8 Seminal Vesicles Neoplastic Cells, Circulating Stromal Cells Cell Line Rectum Cell Nucleus

Organisms5

Mice, Nude Mice, SCID Mice, Transgenic Mice, Inbred BALB C Mice, Inbred C57BL

Diseases37

Prostatic Neoplasms Breast Neoplasms Neoplasm Recurrence, Local Kidney Neoplasms Prostatic Hyperplasia Carcinoma, Renal Cell Neoplasms, Hormone-Dependent Neoplasm Metastasis Adenocarcinoma Disease Progression Lymphatic Metastasis Prostatic Intraepithelial Neoplasia Neoplasm Invasiveness Bone Neoplasms Genetic Predisposition to Disease Lung Neoplasms Neoplasms Carcinoma Ovarian Neoplasms Colonic Neoplasms Prostatic Neoplasms, Castration-Resistant Stomach Neoplasms Pancreatic Neoplasms Cell Transformation, Neoplastic Colorectal Neoplasms Prostatic Diseases Disease Models, Animal Urinary Bladder Neoplasms Neovascularization, Pathologic Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Prostatitis Liver Neoplasms Rectal Neoplasms Uterine Cervical Neoplasms Neoplastic Cells, Circulating Esophageal Neoplasms

Chemicals and Drugs70

Prostate-Specific Antigen Tumor Markers, Biological Receptors, Androgen Androgens Androgen Antagonists Antineoplastic Agents Tosyl Compounds Antineoplastic Agents, Hormonal Neoplasm Proteins Androgen Receptor Antagonists RNA, Messenger Anilides Dihydrotestosterone Finasteride RNA, Small Interfering Metribolone Taxoids Cancer Vaccines Flutamide Anticarcinogenic Agents DNA, Neoplasm PTEN Phosphohydrolase Glutamate Carboxypeptidase II 5-alpha Reductase Inhibitors Antineoplastic Agents, Phytogenic Antigens, Neoplasm Tumor Suppressor Protein p53 Testosterone Congeners Nitriles Androstenols Testosterone Transcription Factors 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Phenylthiohydantoin Azasteroids Receptor, erbB-2 Tumor Suppressor Proteins RNA, Neoplasm Proto-Oncogene Proteins c-akt Proto-Oncogene Proteins MicroRNAs DNA-Binding Proteins Antibodies, Monoclonal Receptors, Estrogen Racemases and Epimerases Estramustine Cisplatin Enzyme Inhibitors Cholestenone 5 alpha-Reductase Leuprolide Paclitaxel Goserelin Glutathione S-Transferase pi Fluorouracil DNA Primers Protein-Serine-Threonine Kinases Ki-67 Antigen Receptor, Epidermal Growth Factor Nuclear Proteins Protein Kinase Inhibitors Oncogene Proteins, Fusion Kallikreins Phosphatidylinositol 3-Kinases Prostatic Secretory Proteins Androgen-Binding Protein Steroid 17-alpha-Hydroxylase Proto-Oncogene Proteins c-bcl-2 Membrane Proteins Trans-Activators Vascular Endothelial Growth Factor A

Analytical, Diagnostic and Therapeutic Techniques and Equipment77

Survival Analysis Prognosis Neoplasm Staging Treatment Outcome Survival Rate Disease-Free Survival Kaplan-Meier Estimate Retrospective Studies Prostatectomy Follow-Up Studies Cystectomy Immunohistochemistry Multivariate Analysis Combined Modality Therapy Orchiectomy Proportional Hazards Models Nephrectomy Cohort Studies Early Detection of Cancer Neoplasm Grading Risk Factors Reverse Transcriptase Polymerase Chain Reaction Xenograft Model Antitumor Assays Neoplasm Transplantation Prospective Studies Digital Rectal Examination Transplantation, Heterologous Blotting, Western Gene Expression Profiling Antineoplastic Combined Chemotherapy Protocols Case-Control Studies Risk Assessment Risk Transurethral Resection of Prostate Biopsy Sensitivity and Specificity Incidence Registries Predictive Value of Tests Biopsy, Needle Odds Ratio Tumor Burden Transfection Brachytherapy Oligonucleotide Array Sequence Analysis SEER Program Tissue Array Analysis Radiotherapy Radiotherapy Dosage Polymerase Chain Reaction Castration Nomograms Logistic Models Molecular Targeted Therapy Disease Models, Animal Models, Biological Reproducibility of Results Drug Screening Assays, Antitumor Radiotherapy, Conformal Chemotherapy, Adjuvant Clinical Trials as Topic Gene Knockdown Techniques Questionnaires Immunoenzyme Techniques Confidence Intervals Mass Screening Drug Administration Schedule In Situ Hybridization, Fluorescence Radiotherapy, Intensity-Modulated Flow Cytometry Immunotherapy Real-Time Polymerase Chain Reaction ROC Curve Genetic Therapy Radiotherapy Planning, Computer-Assisted Radiotherapy, Adjuvant Palliative Care

Psychiatry and Psychology1

Phenomena and Processes44

Cell Survival Gene Expression Regulation, Neoplastic Time Factors Apoptosis Cell Proliferation Genetic Predisposition to Disease Signal Transduction Risk Drug Resistance, Neoplasm Graft Survival Cell Growth Processes Down-Regulation Cell Division Genotype Sensitivity and Specificity Cell Movement Odds Ratio Transfection Mutation Up-Regulation Dose-Response Relationship, Drug Cell Cycle DNA Methylation Promoter Regions, Genetic Polymorphism, Genetic RNA Interference Nomograms Gene Silencing Phosphorylation Gene Expression Base Sequence Genes, Tumor Suppressor Gene Fusion Chromosomes, Human, Pair 8 Polymorphism, Single Nucleotide Transcription, Genetic Alleles Phenotype Diet Drug Synergism Genes, Neoplasm Radiation Tolerance Enzyme Activation Germ-Line Mutation

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena3

Survival National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science10

Survival Rate Incidence Registries SEER Program Radiotherapy, Conformal Base Sequence Molecular Sequence Data Questionnaires Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted

Named Groups4

European Continental Ancestry Group African Americans Survivors African Continental Ancestry Group

Health Care33

Survival Analysis Treatment Outcome Survival Rate Disease-Free Survival Kaplan-Meier Estimate Retrospective Studies Follow-Up Studies Multivariate Analysis Proportional Hazards Models Cohort Studies Risk Factors Prospective Studies Watchful Waiting Case-Control Studies Risk Assessment Risk Sensitivity and Specificity Incidence Age Factors Registries Predictive Value of Tests Odds Ratio SEER Program National Cancer Institute (U.S.)Nomograms Logistic Models Reproducibility of Results Clinical Trials as Topic Questionnaires Confidence Intervals Mass Screening ROC Curve Palliative Care

Geographicals3

United States Sweden Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Survival Analysis Prostate Prognosis Neoplasm Staging Prostatic Neoplasms Breast Neoplasms Treatment Outcome Survival Rate Prostate-Specific Antigen Disease-Free Survival Tumor Markers, Biological Cell Survival Kaplan-Meier Estimate Retrospective Studies Receptors, Androgen Cell Line, Tumor Androgens Androgen Antagonists Neoplasm Recurrence, Local Prostatectomy Follow-Up Studies Cystectomy Kidney Neoplasms Gene Expression Regulation, Neoplastic Prostatic Hyperplasia Immunohistochemistry Carcinoma, Renal Cell Multivariate Analysis Combined Modality Therapy Orchiectomy Neoplasms, Hormone-Dependent Proportional Hazards Models Neoplasm Metastasis Time Factors Adenocarcinoma Nephrectomy Disease Progression Cohort Studies Early Detection of Cancer Mice, Nude Apoptosis Lymphatic Metastasis Prostatic Intraepithelial Neoplasia Neoplasm Invasiveness Bone Neoplasms Cell Proliferation Antineoplastic Agents Neoplasm Grading Tosyl Compounds Survival Tumor Cells, Cultured Risk Factors Reverse Transcriptase Polymerase Chain Reaction Antineoplastic Agents, Hormonal Neoplasm Proteins Xenograft Model Antitumor Assays Genetic Predisposition to Disease Lung Neoplasms Androgen Receptor Antagonists RNA, Messenger Signal Transduction Neoplasms Neoplasm Transplantation Prospective Studies Digital Rectal Examination Anilides Transplantation, Heterologous Blotting, Western Watchful Waiting Gene Expression Profiling Carcinoma Dihydrotestosterone Antineoplastic Combined Chemotherapy Protocols Finasteride Case-Control Studies Risk Assessment Ovarian Neoplasms Risk Drug Resistance, Neoplasm RNA, Small Interfering Graft Survival Cell Growth Processes United States Down-Regulation Cell Division Metribolone Transurethral Resection of Prostate Biopsy Taxoids Genotype Colonic Neoplasms Sensitivity and Specificity Prostatic Neoplasms, Castration-Resistant Cancer Vaccines Flutamide Mice, SCID Incidence Stomach Neoplasms Anticarcinogenic Agents Age Factors

No FAQ available that match "prostate cancer specific survival"